Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

The Nuclear Medicine Department at Ridley-Tree Cancer Center (now part of Sutter Health) has announced greater capabilities to treat prostate cancer using the injectable radioligand therapy, Pluvicto ...

April 24, 2025 (Santa Barbara, CA) The Nuclear Medicine Department at Ridley-Tree Cancer Center, now part of Sutter Health, announces greater capabilities to treat prostate cancer using the injectable ...

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results at the 2025 American Society for Radiation Oncology (ASTRO) ...

Actinium-225, an alpha-emitting radiopharmaceutical, targets cancer cells precisely, sparing healthy tissue, and is being trialed for advanced breast cancer in the U.S. The phase 1b/2 trial involves ...

Iranian nuclear medicine and oncology specialists gathered in Tehran on Thursday to discuss the benefits of ...

There is renewed hope for cancer patients following the introduction of nuclear therapy that promises greater precision and effectiveness. The procedure, known as theranostics, involves injecting ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...

Press releases are posted on Independent.com as a free community service. April 24, 2025 (Santa Barbara, CA) The Nuclear Medicine Department at Ridley-Tree Cancer Center, now part of Sutter Health, ...